Bloomios, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
November 15, 2021 at 12:01 pm EST
Share
Bloomios, Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was USD 2.21 million compared to USD 0.0347 million a year ago. Net loss was USD 0.296209 million compared to USD 0.196682 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.02 a year ago.
For the nine months, sales was USD 6.83 million compared to USD 0.108315 million a year ago. Net loss was USD 1.43 million compared to USD 0.485384 million a year ago. Basic loss per share from continuing operations was USD 0.11 compared to USD 0.04 a year ago.
Bloomios, Inc. manufactures, markets, and distributes hemp-derived supplements and cosmetic products through wholesale distribution channels in the United States, through its wholly owned subsidiary, Bloomios Private Label (BPL). BPL is engaged in the manufacturing, processing, sourcing and distribution of hemp-derived, nootropic and nutraceutical products to wholesalers and retailers. The Company manufactures hemp infused products ranging from human edibles, pet edibles, liquid consumables such as tinctures and shots, topicals, and smokable hemp. It provides support at each step from custom formulation, order fulfillment, and brand development. Its product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages and pet treats. It offers its private-label and white-label customers a collections of customizable hemp products that includes over 80 products across seven categories in addition to custom formulation and manufacturing services.
BLOOMIOS, INC. 